Department of internal medicine, China-Japan Friendship Hospital, Beijing, China.
Department of internal medicine, Beijing Jishuitan Hospital, Beijing, China.
Lupus. 2021 Feb;30(2):238-247. doi: 10.1177/0961203320974081. Epub 2020 Nov 19.
To systematically review and summarize the available literature regarding the association between systemic lupus erythematosus (SLE) and sexual dysfunction (SD) in both sexes.
We retrieved relevant studies from the following databases: PubMed, Embase,Cochrane Library, and Web of Science. Two reviewers independently reviewed the studies in our sample, assessed their validity, and extracted relevant data. Sensitivity and subgroup analyses were performed to distinguish sources of heterogeneity.
Our search resulted in a sample of eight eligible studies, which involved 758 patients in the SLE group and 1724 individuals in the control group. The pooled RR for the increased risk for SD compared to those in the control group was 1.80 (95%CI 1.12-2.87). Subgroup analysis by sex revealed that males (pooled RR = 2.98, 95%CI 2.41-3.68) had a higher risk of SD compared to females (pooled RR = 1.56, 95%CI 0.99-2.48). Females with SLE had significantly lower values in FSFI compared to the healthy individuals (WMD=-0.224, 95%CI -0.441 to -0.078). Age of participants and the quality of studies might influence the results.
Our meta-analysis suggests that SLE is significantly associated with an increased risk of sexual dysfunction. It is of great urgency to implement for active interventions that aimed to treat or prevent SD among SLE patients.
系统回顾和总结现有文献,探讨系统性红斑狼疮(SLE)与两性患者性功能障碍(SD)的相关性。
我们从以下数据库中检索相关研究:PubMed、Embase、Cochrane 图书馆和 Web of Science。两位审阅者独立审阅了我们样本中的研究,评估其有效性并提取相关数据。进行敏感性和亚组分析以区分异质性来源。
我们的搜索结果纳入了 8 项符合条件的研究,其中 SLE 组涉及 758 例患者,对照组涉及 1724 例个体。与对照组相比,SD 风险增加的合并 RR 为 1.80(95%CI 1.12-2.87)。按性别进行的亚组分析显示,男性(合并 RR=2.98,95%CI 2.41-3.68)与女性(合并 RR=1.56,95%CI 0.99-2.48)相比,SD 风险更高。SLE 女性的 FSFI 值明显低于健康个体(WMD=-0.224,95%CI -0.441 至 -0.078)。参与者的年龄和研究质量可能会影响结果。
我们的荟萃分析表明,SLE 与性功能障碍风险增加显著相关。迫切需要针对 SLE 患者实施积极的干预措施,以治疗或预防 SD。